| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $6.55 | - | - |
| Q4'25 | $4.28 | $4.50 | +5.2% |
| Q3'25 | $5.81 | $5.87 | +1.1% |
| Q2'25 | $4.23 | $4.28 | +1.2% |
| Q1'25 | $4.10 | $4.02 | -1.9% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $94.3B | - | - |
| Q4'25 | - | $67.3B | - |
| Q3'25 | - | $86.2B | - |
| Q2'25 | - | $63.2B | - |
| Q1'25 | - | $63.7B | - |
Market Data
COST is currently trading at $913.70, giving Costco Wholesale Corporation a market cap of 407.81B and a P/E ratio of 46.1. Today's range spans $907.21–$916.73, with shares opening at $912.47 and moving up $0.87 (0.1%) from the prior close. DailyIQ's technical score sits at 14/100 (SELL) with a news sentiment reading of 61/100.
Over the past year COST has traded between $844.06 and $1096.50 - the current price is +8.3% off the 52-week low and -16.7% from the high. 46 analysts cover the stock with a Buy consensus and a mean 12-month target of $1080.33 (range $740.00–$1315.00), implying upside of +18.2%.
Factor models are actively underweighting COST: large-cap, Consumer Defensive, 407.81B market cap, 14/100 (SELL), bullish sentiment (61/100). Price: $913.70 (in the lower half of its 52-week range). (P/E: 46.1) Momentum and trend-following strategies reduce exposure when scores drop below the 14/100 threshold; quality factors recalibrate; low-vol strategies find better risk-adjusted alternatives elsewhere in the sector. Annual range: $844.06–$1096.50. The systematic de-risking compounds the fundamental concern.
The current SELL phase for COST (14/100) at $913.70 (in the lower half of its 52-week range) suggests that the market is discounting either a fundamental deterioration or a sector headwind that hasn't fully appeared in the earnings line yet. Sentiment at 61/100 (bullish) confirms that news flow is not providing a counternarrative. At 407.81B in Consumer Defensive capitalization, COST has the liquidity for institutional exits to be orderly — but orderly doesn't mean shallow within the $844.06–$1096.50 range.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).